226 related articles for article (PubMed ID: 31673101)
21. Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy.
McHugh LA; Kriajevska M; Mellon JK; Griffiths TR
Urology; 2007 Feb; 69(2):390-4. PubMed ID: 17320695
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
[TBL] [Abstract][Full Text] [Related]
23. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
[TBL] [Abstract][Full Text] [Related]
24. Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas.
Li Y; Fu SY; Wang LH; Wang FY; Wang NN; Cao Q; Wang YT; Yang JY; Wu CF
Cancer Lett; 2015 Dec; 369(1):86-96. PubMed ID: 26254539
[TBL] [Abstract][Full Text] [Related]
25. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms.
Sun F; Wang H; Nie J; Hong B
Anticancer Agents Med Chem; 2022; 22(17):2920-2926. PubMed ID: 35430981
[TBL] [Abstract][Full Text] [Related]
26. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
[TBL] [Abstract][Full Text] [Related]
27. The combination of disulfiram and copper for cancer treatment.
Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
[TBL] [Abstract][Full Text] [Related]
28. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
[TBL] [Abstract][Full Text] [Related]
29. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
[TBL] [Abstract][Full Text] [Related]
30. Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy.
Swetha KL; Sharma S; Chowdhury R; Roy A
Pharmacol Rep; 2020 Dec; 72(6):1749-1765. PubMed ID: 32617902
[TBL] [Abstract][Full Text] [Related]
31. Disulfiram and Its Copper Chelate Attenuate Cisplatin-Induced Acute Nephrotoxicity in Rats Via Reduction of Oxidative Stress and Inflammation.
Khairnar SI; Mahajan UB; Patil KR; Patel HM; Shinde SD; Goyal SN; Belemkar S; Ojha S; Patil CR
Biol Trace Elem Res; 2020 Jan; 193(1):174-184. PubMed ID: 30825159
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
33. Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.
Zhang J; Miao L; Guo S; Zhang Y; Zhang L; Satterlee A; Kim WY; Huang L
J Control Release; 2014 May; 182():90-6. PubMed ID: 24637468
[TBL] [Abstract][Full Text] [Related]
34. Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines.
Jivan R; Damelin LH; Birkhead M; Rousseau AL; Veale RB; Mavri-Damelin D
J Cell Biochem; 2015 Oct; 116(10):2334-43. PubMed ID: 25846272
[TBL] [Abstract][Full Text] [Related]
35. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin.
Chisholm CL; Wang H; Wong AH; Vazquez-Ortiz G; Chen W; Xu X; Deng CX
Oncotarget; 2016 Dec; 7(51):84439-84452. PubMed ID: 27806319
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.
O'Brien A; Barber JE; Reid S; Niknejad N; Dimitroulakos J
Anticancer Res; 2012 Jul; 32(7):2679-88. PubMed ID: 22753726
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
[TBL] [Abstract][Full Text] [Related]
38. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
39. Disulfiram's Anticancer Activity: Evidence and Mechanisms.
Jiao Y; Hannafon BN; Ding WQ
Anticancer Agents Med Chem; 2016; 16(11):1378-1384. PubMed ID: 27141876
[TBL] [Abstract][Full Text] [Related]
40. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions.
Jiao Y; Hannafon BN; Zhang RR; Fung KM; Ding WQ
Oncotarget; 2017 Mar; 8(11):17908-17920. PubMed ID: 28107189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
